Theriva Biologics, Inc. Number of Reporting Units
Theriva Biologics, Inc. (TOVX) reported Number of Reporting Units of 1 item for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Notes
us-gaap:NumberOfReportingUnits · last filed 2022-11-10
- 2022-09-30: Number of Reporting Units 9 month 1.00 item.
- 2022-06-30: Number of Reporting Units 6 month 1.00 item.
| Period end | Number of Reporting Units 6 month | Number of Reporting Units 9 month |
|---|---|---|
| 2022-09-30 | 1.00 item 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 1.00 item 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |